Akari Therapeutics Management
Management criteria checks 2/4
Akari Therapeutics' CEO is Rachelle Jacques, appointed in Mar 2022, has a tenure of 2.08 years. total yearly compensation is $1.56M, comprised of 39.5% salary and 60.5% bonuses, including company stock and options. directly owns 0.98% of the company’s shares, worth €85.95K. The average tenure of the management team and the board of directors is 1.6 years and 4.2 years respectively.
Key information
Rachelle Jacques
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 39.5% |
| CEO tenure | 2.1yrs |
| CEO ownership | 1.0% |
| Management average tenure | 1.6yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$616k | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$4m | US$458k | -US$18m |
Compensation vs Market: Rachelle's total compensation ($USD1.56M) is above average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Rachelle's compensation has been consistent with company performance over the past year.
CEO
Rachelle Jacques (52 yo)
2.1yrs
Tenure
US$1,560,141
Compensation
Ms. Rachelle Suzanne Jacques serves as President, CEO & Director at Akari Therapeutics, Plc since March 31, 2022. She serves as Non-Executive Director at uniQure N.V. since October 21, 2021. She serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.1yrs | US$1.56m | 0.98% $ 85.9k | |
| Interim Chief Financial Officer | less than a year | US$546.82k | no data | |
| Chief Operating Officer | 1.8yrs | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Executive VP & Chief Medical Officer | 1.4yrs | no data | no data |
1.6yrs
Average Tenure
54yo
Average Age
Experienced Management: CLA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.1yrs | US$1.56m | 0.98% $ 85.9k | |
| Independent Director | 7.8yrs | US$77.12k | 0.13% $ 11.1k | |
| Chairman | 8.6yrs | US$113.00k | 14.71% $ 1.3m | |
| Independent Director | less than a year | US$35.18k | no data | |
| Independent Director | less than a year | US$9.81k | 16.5% $ 1.4m | |
| Independent Director | 6.3yrs | US$61.78k | 0.13% $ 11.1k |
4.2yrs
Average Tenure
63yo
Average Age
Experienced Board: CLA's board of directors are considered experienced (4.2 years average tenure).